Twitter feed

Feb. 2020     

Solvay Ventures announces today its equity investment in Invizius, the University of Edinburgh spin-out developing potentially lifesaving products that reduce complications rates suffered by dialysis patients. Solvay Ventures invests alongside Mercia Asset Management, Downing Ventures, the University of Edinburgh’s Old College Capital fund and the Scottish Investment Bank.

Jan. 2020     

Invizius, the University of Edinburgh spin-out which is developing potentially lifesaving products for dialysis patients, has made four high-profile appointments as it prepares to enter the next stage of its development.

Oct. 2019     

Invizius, the Univerity of Edinburgh spin-out whose technology could help reduce the high death rates amongst dialysis patients, has raised £2.75m from a consortium of investors.

Feb. 2019

Invizius has been named by FierceMedTech as one of 2018’s Fierce 15 med tech companies, designating it as one of the most promising private companies in the industry.

Oct. 2018

Invizius has been named Best Innovative MedTech company at the prestigious OBN Awards.

Apr. 2018

University of Edinburgh spinout, Invizius, has secured £0.5m seed investment from Mercia Fund Managers.